Singapore Vet 2021 New Dates

SINGAPORE, July 22, 2020 – (JCN Newswire) – After the recent announcement of Singapore Vet 2020’s postponement, the organisers of Singapore Vet – CloserStill Media, today announced the...

Agilex Biolabs and Endpoints News Present ‘How to Move Trials to Australia’ Webinar

Adelaide, AUS, July 22, 2020 - (ACN Newswire) - Agilex Biolabs, Australia's largest specialist bioanalytical laboratory for clinical trials, and Endpoints News launched a...

Avance Clinical Contracted for Atossa Therapeutics AT-301 Nasal Spray Clinical Study, Atossa’s Second COVID-19...

The leading Australian CRO for biotechs and Frost & Sullivan 2020 Asia-Pacific CRO Market Leadership Award winner Avance Clinical has been contracted to conduct...

Antengene Corporation Closes US$97 Million Series C Financing to Support Ongoing Drug Development and...

Antengene Corporation, a leading innovative hematology and oncology-focused biopharmaceutical company dedicated to discovering, developing and commercializing global first-in-class and best-in-class therapies, today announced that...

Evolution Wellness Solutions Launches Cloud-Based Membership Management System, Circuit(TM)

- Seamless, end-to-end, feature-rich membership management system packs a powerful punch - Built by the gym industry for the gym industry, Circuit(TM) is the superior...

Cariflex to Double its Polyisoprene Latex Capacity at the Paulinia Facility in Brazil

Cariflex Board of Directors approved the approximate $50 million capital project in April 2020 The new plant is expected to be operational in...

Dr. Burkhard Dick Joins the EuroEyes International Medical Advisory Board

Empowers its European Staff to Capture Advanced Medical Knowledge, Promotes Innovation in Technology, and Enhances the Quality and Service Standard of the Refractive Field EuroEyes...

Novotech Webinar: Why the Asia-Pacific is Attracting 10,000 Oncology Trials and How Biotechs Can...

The leading Asia-Pacific biotech specialist CRO Novotech is again collaborating with the prestigious biotech and pharma news platform Endpoints News. This webinar focusses on...

HK Main-Board Listed Tianda Pharmaceuticals(00455.HK) , A Promising Outlook for Growth

With the successive introduction of the "Opinions on Facilitating the Inheritance, Innovation and Development of Traditional Chinese Medicine (TCM)" in certain provinces in mainland...

Avance Clinical榮獲Frost & Sullivan 2020亞太CRO市場領導力獎

澳大利亞阿德萊德, 2020年7月9日 - (亞太商訊)  - Avance Clinical在全球遠程線上獎頒獎典禮上榮獲由Frost & Sullivan 頒發的久負盛名的“2020亞太CRO市場領導力獎”,其是澳大利亞在CRO 生物技術方面領先的公司。 關於 Frost & Sullivan: “'Frost & Sullivan最佳實踐獎'是對在各自行業中表現出色的頂尖公司的肯定與表彰。獲獎者都是Frost & Sullivan公司分析師進行深入訪談、分析和全方位的二次調研後確定的。通常Frost & Sullivan公司分析師會對候選公司的收入、市場份額、產能和對行業的總體貢獻進行調研,以確定是否符合最佳實踐獎獲得者的要求。” 這是該公司獲得的首個Frost & Sullivan獎項,其在過去一年裡在亞太地區發展迅速。 Avance Clinical 的首席執行官 Yvonne Lungershausen稱讚了她的團隊——由來自澳大利亞和新西蘭的100多名臨床試驗專家組成。 “我們已經證明:始終注重贊助商的文化和靈活主動的策略讓我們每次都會脫穎而出,我們的業務回頭率高達75%。而這一點得到了Frost &...

Avance Clinical Wins Frost & Sullivan 2020 Asia-Pacific CRO Market Leadership Award

The leading Australian CRO for biotechs, Avance Clinical, accepted the prestigious Frost & Sullivan 2020 Asia-Pacific CRO Market Leadership Award at a global virtual...

Research on Free-state Nicotine and Coronavirus Reveals Facts More Complex than we Thought

On February 9, Chinese academician Zhong Nanshan published a retrospective study on novel coronavirus cases in medRxiv, a medical preprint magazine. According to Zhong's...

Favored by Capital Market Again, MicroPort’s CRM Business Brings in New Investor

Thanks to capital market's growing expectation for the aging population and accelerated substitution of imported medical devices, China's medical devices industry has entered a...

Hua Medicine Announces Positive 24-Week Topline Results of Phase III Metformin Combination Trial of...

Hua Medicine today announced the positive 24-week top-line results from HMM0302, a Phase III registration trial in China of its global first-in-class glucokinase activator...

Captiva Verde Land Corp Announces Solargram Farms Corporation Receives Health Canada Standard Cultivation Cannabis...

Captiva Verde Land Corp. (CSE: PWR) (the "Company") is extremely pleased to announce that Solargram Farms Corporation ("Solargram"), a Canadian controlled private corporation, having...

Jacobson Pharma Announces FY2020 Annual Results

Delivers Solid Performance Amidst Market Challenges; Revenue Increases +6.3%; Maintains Full-Year Dividend Per Share of HK4.5 Cents Jacobson Pharma Corporation Limited ("Jacobson Pharma" or the "Company"; Stock...

Hygeia Healthcare Successfully Listed on Main Board of SEHK, Further Strengthen Its Leading Market...

The largest oncology healthcare group in China, Hygeia Healthcare Holdings Co., Limited ("Hygeia Healthcare" or the "Company", together with its subsidiaries, the "Group", stock...

Launch of EIU report showing lack of integrated follow up care can increase risk...

Rehabilitation services designed to keep patients well and prevent their hospital readmission is key to reducing the incidence and cost of recurring (secondary) heart...

Novotech Partners with South Korea’s Pusan National University Hospital

The leading Asia-Pacific biotech specialist CRO Novotech has partnered with South Korea's world-class Pusan National University Hospital (PNUH) based in Busan, South Korea's second...

Hua Medicine Successfully Completes SEED (HMM0301), Dorzagliatin’s Phase III Monotherapy Trial

        Hua Medicine (the "Company", Stock Code: 2552.HK), a leading innovative drug development company focused on developing novel therapies for the treatment of diabetes, today...